Research Article
Analysis of the Chemotherapy-Free Interval following Image-Guided Ablation in Sarcoma Patients
Figure 2
Progression-free survival. (a) Median local progression-free survival after ablation of sarcoma metastases was not reached. (b) Median distant progression-free survival was 6.7 months (95% CI: 4.4–11.2 months) after ablation of sarcoma metastases.
(a) |
(b) |